Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary D Novack
W Daniel Stamer

Showing results (1-10 of 548) with videos related to

Pageof 55
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 14, 2015
The "T" in JOPTGary D Novack, W Daniel Stamer
Clinical Therapeutics|October 17, 2002
Compared topical ocular olopatadine 0.1% (Patanol) and loteprednol etabonate 0.2% (Alrex) in an allergen challenge modelGary D Novack
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 22, 2019
Eyes on New Product DevelopmentGary D Novack
The Ocular Surface|July 28, 2011
Drop size: an issue wrapped in a non-issue wrapped in an issueGary D Novack
The Ocular Surface|May 7, 2011
Withdrawal of approved drugsGary D Novack
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 8, 2022
Eyes on New Product DevelopmentGary D Novack
Ophthalmology. Glaucoma|March 22, 2022
Re: Schlenker et al.: How mean intraocular pressures are failing patients (Ophthalmology Glaucoma. 2021;4:553-557)Gary D Novack
The Ocular Surface|August 18, 2010
Personalized medicine and the ocular surfaceGary D Novack
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 23, 2020
Eyes on New Product DevelopmentGary D Novack
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 15, 2025
Eyes on New Product DevelopmentGary D Novack
Pageof 55

Showing results (1-10 of 548) with videos related to

Sort By:
Pageof 55
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 14, 2015
The "T" in JOPTGary D Novack, W Daniel Stamer
Clinical Therapeutics|October 17, 2002
Compared topical ocular olopatadine 0.1% (Patanol) and loteprednol etabonate 0.2% (Alrex) in an allergen challenge modelGary D Novack
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 22, 2019
Eyes on New Product DevelopmentGary D Novack
The Ocular Surface|July 28, 2011
Drop size: an issue wrapped in a non-issue wrapped in an issueGary D Novack
The Ocular Surface|May 7, 2011
Withdrawal of approved drugsGary D Novack
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 8, 2022
Eyes on New Product DevelopmentGary D Novack
Ophthalmology. Glaucoma|March 22, 2022
Re: Schlenker et al.: How mean intraocular pressures are failing patients (Ophthalmology Glaucoma. 2021;4:553-557)Gary D Novack
The Ocular Surface|August 18, 2010
Personalized medicine and the ocular surfaceGary D Novack
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 23, 2020
Eyes on New Product DevelopmentGary D Novack
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 15, 2025
Eyes on New Product DevelopmentGary D Novack
Pageof 55